Elicera Therapeutics AB (ELIC.ST) Q1 2023 Earnings

16MayExpected
Q4 2022
Q1 2023
-0.2
-0.17
-0.14
-0.11

Details

Expected EPS
N/A
Actual EPS
-0.1146
Surprise EPS
-0.11
Surprise Percent
+∞%

Description

Elicera Therapeutics AB (ELIC.ST) has reported earnings of -0.1146 per share for Q1 2023.

0 Comments

Share your thoughts